- Home
- NPT vs DYAI Comparison
NPT vs DYAI Comparison
Compare NPT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | DYAI |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 32.5M |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | NPT | DYAI |
|---|---|---|
| Price | $2.31 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 7.5M | 295.6K |
| Earning Date | 05-23-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $0.65 |
| 52 Week High | $22.38 | $1.35 |
Technical Indicators
Market Signals| Indicator | NPT | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 51.90 |
| Support Level | $1.19 | $0.69 |
| Resistance Level | $6.15 | $0.91 |
| Average True Range (ATR) | 1.18 | 0.06 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 9.00 | 48.54 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.